Atara Biotherapeutics, Inc. Intellectual Property Contracts & Agreements
14 Contracts & Agreements
- License Agreements (14 contracts)
- Fourth Amended and Restated Exclusive License Agreement between Atara Biotherapeutics, Inc. and the Counsel of the Queensland Institute of Medical Research, dated December 17, 2021 (Filed With SEC on February 28, 2022)
- Deed of Amendment Number 1 to Third Amended and Restated License Agreement dated April 21, 2021 (Filed With SEC on August 9, 2021)
- Research, Development and License Agreement, by and between Atara Biotherapeutics, Inc. and Bayer AG, dated December 4, 2020 (Filed With SEC on March 1, 2021)
- Third Amended and Restated Exclusive License Agreement, by and between Atara Biotherapeutics, Inc. and the Counsel of the Queensland Institute of Medical Research, dated August... (Filed With SEC on November 9, 2020)
- Second Amended and Restated Exclusive License Agreement, by and between Atara Biotherapeutics, Inc. and the Counsel of the Queensland Institute of Medical Research, dated August... (Filed With SEC on November 7, 2019)
- Amendment No. 1 to the Exclusive License Agreement, by and between Atara Biotherapeutics, Inc. and Memorial Sloan Kettering Cancer Center, dated as of August 30, 2018 (Filed With SEC on February 26, 2019)
- Amended and Restated Exclusive License Agreement, by and between Atara Biotherapeutics, Inc. and the Council of the Queensland Institute of Medical Research, dated September 23,... (Filed With SEC on August 1, 2018)
- EXCLUSIVE LICENSE AGREEMENT for MSKs technology EBV/CMV and WT1 specific T-cells TABLE OF CONTENTS (Filed With SEC on June 29, 2015)
- EXCLUSIVE LICENSE AGREEMENT by and between AMGENINC. and SANTA MARIA BIOSCIENCES, INC. Dated as of September 7, 2012 TABLE OF CONTENTS (Filed With SEC on July 10, 2014)
- EXCLUSIVE LICENSE AGREEMENT by and between AMGENINC. and PINTA BIOSCIENCES, INC. Dated as of September 7, 2012 (Filed With SEC on July 10, 2014)
- EXCLUSIVE LICENSE AGREEMENT by and between AMGENINC. and NINABIOSCIENCES, INC. Dated as of September 7, 2012 (Filed With SEC on July 10, 2014)
- EXCLUSIVE LICENSE AGREEMENT by and between AMGENINC. and SANTA MARIA BIOSCIENCES, INC. Dated as of September 7, 2012 TABLE OF CONTENTS (Filed With SEC on June 20, 2014)
- EXCLUSIVE LICENSE AGREEMENT by and between AMGENINC. and PINTA BIOSCIENCES, INC. Dated as of September 7, 2012 (Filed With SEC on June 20, 2014)
- EXCLUSIVE LICENSE AGREEMENT by and between AMGENINC. and NINABIOSCIENCES, INC. Dated as of September 7, 2012 (Filed With SEC on June 20, 2014)
